N. Mitsiades

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

G. Chrousos, S. Bornstein, D. Torpy, 1998, Endocrinology.

Recurring oral giant cell lesion in a child with X-linked hypophosphatemic rickets: clinical manifestation of occult parathyroidism?

G. Chrousos, D. Sun, C. Stratakis, 1995, The Journal of pediatrics.

Skin Manifestations of Cushing Disease in Children and Adolescents Before and After the Resolution of Hypercortisolemia

G. Chrousos, N. Mitsiades, C. Mitsiades, 1998, Pediatric dermatology.

Corticotropin-releasing hormone (CRH) and immunotolerance of the fetus.

G. Chrousos, A. Makrigiannakis, A. Gravanis, 2003, Biochemical pharmacology.

Dopamine affects the in vitro basal secretion of rat placenta opioids in an opioid and dopamine receptor type-specific manner.

G. Chrousos, A. Margioris, C. Stratakis, 1996, European journal of pharmacology.

The mercy of adrenocortical tumor cells on lymphocytes.

G. Chrousos, S. Bornstein, T. Lohmann, 1998, Endocrine research.

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

D. Torpy, M. Tsokos, E. Webster, 1998, Endocrinology.